|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,930.00 KRW | +1.03% |
|
+4.46% | -19.95% |
| 09/25/09 | Dongkook Life Science Approves KRW17 Billion Facility Investment to Expand Operations | MT |
| 09/25/09 | Dongkook Life Science to invest 17 billion won in new facility | RE |
| Market Cap | 9.37TCr 6.19Cr 5.34Cr 4.92Cr 4.62Cr 8.66Cr 586.18Cr 8.75Cr 58Cr 23Cr 286.15Cr 23Cr 23Cr 994.73Cr | P/E Ratio 2024 * |
-
| P/E Ratio 2025 | 13.3x |
|---|---|---|---|---|---|
| Enterprise Value | 13TCr 8.29Cr 7.15Cr 6.59Cr 6.18Cr 12Cr 784.65Cr 12Cr 78Cr 30Cr 383.04Cr 31Cr 30Cr 1.33TCr | EV / Sales 2024 * |
-
| EV / Sales 2025 | 1.14x |
| Free-Float |
37.79% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +1.03% | ||
| 1 week | +4.46% | ||
| Current month | +1.56% | ||
| 1 month | -6.39% | ||
| 3 months | -15.07% | ||
| 6 months | -22.59% | ||
| Current year | -19.95% |
| 1 week | 2,650 |  | 2,945 |
| 1 month | 2,615 | | 3,150 |
| Current year | 2,615 | | 4,045 |
| 1 year | 2,615 | | 5,350 |
| 3 years | 2,615 | | 8,375 |
| 5 years | 2,615 | | 8,375 |
| 10 years | 2,615 | | 8,375 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jae-Won Park
CEO | Chief Executive Officer | 62 | 01/01/2021 |
Su-Jin Kwon
PRN | Corporate Officer/Principal | 58 | - |
Yeong-Seon Kim
PRN | Corporate Officer/Principal | 57 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Gi-Beum Kwon
CHM | Chairman | 59 | 08/08/2017 |
Jae-Won Park
BRD | Director/Board Member | 62 | - |
Byeong-Uk Choi
BRD | Director/Board Member | 61 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 09/04 | Buy | Executive/Senior Manager | 10,000 | 0.0313% | ||
| 19/25/19 | Free | Chairman | 17,76,380 | 11.1079% | ||
| 18/25/18 | Free | Executive/Senior Manager | 3,420 | 0.0214% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.03% | +4.46% | -34.74% | - | 6.12Cr | |
| +4.23% | +15.84% | -32.30% | -49.33% | 239.09Cr | |
| +3.00% | +0.13% | -56.41% | -87.91% | 161.64Cr | |
| +1.75% | +5.65% | -3.41% | +1.23% | 33Cr | |
| Average | +2.50% | +5.03% | -31.72% | -45.34% | 109.84Cr | |
| Weighted average by Cap. | +3.55% | +5.59% | -39.07% | -59.93% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 13TCr 8.71Cr 7.51Cr 6.92Cr 6.5Cr 12Cr 824.51Cr 12Cr 82Cr 32Cr 402.5Cr 33Cr 32Cr 1.4TCr | 13TCr 8.62Cr 7.43Cr 6.84Cr 6.43Cr 12Cr 815.3Cr 12Cr 81Cr 32Cr 398Cr 32Cr 32Cr 1.38TCr |
| Net income | 224.47Cr 14.84L 12.79L 11.78L 11.07L 20.74L 14Cr 20.97L 1.39Cr 54.39L 6.85Cr 55.62L 54.46L 24Cr | 865.83Cr 57.23L 49.35L 45.46L 42.69L 80L 54Cr 80.87L 5.38Cr 2.1Cr 26Cr 2.15Cr 2.1Cr 92Cr |
| Net Debt | 4.07TCr 2.69Cr 2.32Cr 2.14Cr 2.01Cr 3.76Cr 254.43Cr 3.8Cr 25Cr 9.86Cr 124.21Cr 10Cr 9.87Cr 431.76Cr | 3.17TCr 2.1Cr 1.81Cr 1.67Cr 1.56Cr 2.93Cr 198.47Cr 2.96Cr 20Cr 7.69Cr 97Cr 7.86Cr 7.7Cr 336.8Cr |
Employees
100
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/26/15 | 2,930.00 ₩ | +1.03% | 63,041 |
| 12/26/12 | 2,900.00 ₩ | +2.65% | 51,841 |
| 11/26/11 | 2,825.00 ₩ | +4.82% | 43,931 |
| 10/26/10 | 2,695.00 ₩ | -3.23% | 1,21,683 |
| 09/26/09 | 2,785.00 ₩ | +4.31% | 51,025 |
- Stock Market
- Stocks
- A303810 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition